Jump to navigation

  • IHME
  • GHDx
  • GBD Compare
Home
Main menu
  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
      • IHME Foundations
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Explore section

Results

  • GBD Results Tool
  • Data Visualizations
  • Country Profiles
  • GBD 2019 Cause and Risk Summaries
  • US Health
  • Policy Reports
  • Research Articles
  • Infographics
  • Topics
  • Data & Tools

Malaria — Level 3 cause


Summary Malaria was responsible for 643 000 deaths (95% UI 302 000–1 150 000) in 2019. 356 000 deaths (169 000–626 000) occurred in children under 5 years, comprising 7·1% (4·0–10·4) of total deaths in that age group.

Definition This cause incorporates death and disability resulting from acute infection for both Plasmodium falciparum and Plasmodium vivax and the long-term neurological consequences in a proportion of children who survive cerebral malaria.

Total sources
Incidence 4089
Prevalence 1616
Remission 0
Causes of death 3877
Other 5354
Table 1: Total sources used in GBD 2019 estimation
What is new in GBD 2019?
  • •Seven new national Plasmodium parasite rate surveys were added, amounting to 1929 household cluster points.
  • •An annual update for routine surveillance data (reported incidence) was completed for all malaria-endemic countries.
  • •New net delivery and use data for insecticide-treated bednets were acquired and models updated.
  • •A new model for effective treatment with an antimalarial drug was developed, which included sub-models for treatment seeking, drug-specific treatment failure, and proportional drug use.
  • •New intervention data for indoor residual spraying were obtained and mapped.
  • •A global case fatality rate approach was implemented to standardise mortality estimation methods in all endemic countries.
Prevalence
Incidence
Deaths
YLLs
YLDs
DALYs
Cases
(millions)
Rate (per 100 000)
Cases
(millions)
Rate (per 100 000)
Deaths
(millions)
Rate (per 100 000)
YLLs
(millions)
Rate (per 100 000)
YLDs
(millions)
Rate (per 100 000)
DALYs
(millions)
Rate (per 100 000)
2019
Both Sexes
181
(163
to 203)
2466·3
(2226·8
to 2773·0)
231
(186
to 290)
3247·0
(2602·1
to 4109·6)
0·643
(0·302
to 1·15)
9·0
(4·2
to 16·0)
43·8
(21·1
to 78·0)
632·0
(305·3
to 1122·5)
2·61
(1·82
to 3·65)
36·2
(25·1
to 50·6)
46·4
(23·5
to 80·1)
668·1
(337·3
to 1152·2)
Females
91·3
(82·3
to 103)
2541·6
(2294·0
to 2858·1)
116
(93·2
to 145)
3334·4
(2666·8
to 4223·5)
0·310
(0·147
to 0·550)
8·8
(4·2
to 15·6)
21·4
(10·3
to 37·0)
636·4
(307·6
to 1102·7)
1·57
(1·09
to 2·21)
43·9
(30·4
to 61·8)
22·9
(11·8
to 38·7)
680·3
(348·5
to 1148·6)
Males
89·4
(80·7
to 100)
2394·4
(2161·9
to 2689·4)
116
(92·9
to 145)
3164·0
(2537·4
to 4001·6)
0·334
(0·156
to 0·600)
9·1
(4·3
to 16·3)
22·5
(10·7
to 39·9)
628·9
(300·0
to 1117·9)
1·04
(0·720
to 1·46)
28·6
(19·8
to 40·2)
23·5
(11·7
to 41·0)
657·5
(327·1
to 1151·5)
Percentage change 2010-19
Both Sexes
–2·1%
(–12·2
to 10·1)
–7·8%
(–17·4
to 3·7)
–12·3%
(–23·3
to –2·1)
–16·3%
(–27·2
to –6·2)
–29·3%
(–53·1
to 1·1)
–34·4%
(–56·5
to –6·1)
–33·4%
(–55·7
to –4·6)
–36·1%
(–57·6
to –8·6)
–5·9%
(–13·3
to 3·3)
–10·8%
(–17·8
to –2·1)
–32·3%
(–53·9
to –4·5)
–35·1%
(–55·8
to –8·6)
Females
–1·4%
(–11·8
to 10·8)
–7·3%
(–16·9
to 4·4)
–11·9%
(–22·8
to –1·7)
–16·0%
(–26·9
to –5·9)
–29·7%
(–53·1
to 0·1)
–34·9%
(–56·4
to –7·7)
–34·2%
(–56·0
to –6·7)
–36·8%
(–57·7
to –10·7)
–3·3%
(–10·9
to 5·8)
–8·6%
(–15·9
to 0·1)
–32·7%
(–53·5
to –6·5)
–35·5%
(–55·6
to –10·5)
Males
–2·7%
(–12·7
to 9·3)
–8·3%
(–17·8
to 2·9)
–12·7%
(–23·7
to –2·4)
–16·6%
(–27·5
to –6·5)
–28·9%
(–53·0
to 3·0)
–34·1%
(–56·5
to –4·8)
–32·6%
(–55·6
to –3·3)
–35·5%
(–57·4
to –7·2)
–9·6%
(–16·8
to –0·6)
–13·9%
(–20·8
to –5·2)
–31·9%
(–53·7
to –3·4)
–34·8%
(–55·7
to –7·3)
Numbers in parentheses are 95% uncertainty intervals.
Table 2: Global prevalence, incidence, deaths, YLLs, YLDs, and DALYs in counts and age-standardised rates for both sexes combined, females, and males, 2019, with percentage change between 2010 and 2019
Deaths YLLs YLDs DALYs
1990 12th 9th 53rd 10th
2010 16th 7th 54th 8th
2019 21st 11th 58th 15th
Table 3: Rank among Level 3 causes for global deaths, YLLs, YLDs, and DALYs in 1990, 2010, and 2019, for both sexes combined
Figure 1: Composition of DALYs by YLLs and constituent sequelae YLDs for both sexes combined, 2019
No Legend
Figure 2: Age-standardised DALY rates for each location by SDI, both sexes combined, 2019
Figure 3: Composition of DALYs by YLLs and YLDs, age group, and sex, 2019
No Legend
Figure 4: Age-standardised DALY rates (per 100 000) by location, both sexes combined, 2019

Results

  • GBD Results Tool
  • Data Visualizations
  • Country Profiles
  • GBD 2019 Cause and Risk Summaries
  • US Health
  • Policy Reports
  • Research Articles
  • Infographics
  • Topics
  • Data & Tools

Stay connected

     

IHME

Institute for Health Metrics and Evaluation

Population Health Building/Hans Rosling Center

3980 15th Ave. NE, Seattle, WA 98195

UW Campus Box #351615

Tel: +1-206-897-2800

Fax: +1-206-897-2899

© 2020 University of Washington

  • Privacy policy
  • Login

  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Projects

  • Global Burden of Disease (GBD)
  • Disease Control Priorities Network (DCPN)
  • ABCE+: A Focus on Antiretroviral Therapy (ART)
  • Access, Bottlenecks, Costs, and Equity (ABCE)
  • Efficacy to Effectiveness
  • Viral Load Pilot
  • Salud Mesoamérica Initiative
  • Improving Methods to Measure Comparable Mortality by Cause
  • Verbal Autopsy (VA)
  • Disease Expenditure (DEX)
  • Local Burden of Disease
  • State-level disease burden initiative in India
  • US Counties Drivers of Health Study
  • University of Washington Center for Health Trends and Forecasts